Skip to content

Clinical trials

Completed Asthma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Status: Completed Country / region: China Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20093
20106
20113
20126
20134
20145
20158
20163
20175
20186
20194
20203
202110
20229
20237
20248
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca15
GlaxoSmithKline13
Guangzhou Institute of Respiratory Disease5
Novartis Pharmaceuticals5
Second Affiliated Hospital, Zhejiang University, School of Medicine4
Keymed Biosciences Co.Ltd3
Shanghai Hengrui Pharmaceutical Co., Ltd.3
Shanghai Xin Huanghe Pharmaceutical Co., Ltd.3
Boehringer Ingelheim2
Chiesi Farmaceutici S.p.A.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma98
Pulmonary Disease, Chronic Obstructive9
Rhinitis, Allergic7
Dermatitis, Atopic5
Hypersensitivity4
Lung Diseases2
Lung Diseases, Obstructive2
Respiratory Tract Diseases2
Rhinitis2
Airway Remodeling1

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.